A remarkable clinical response to immune checkpoint inhibitors of MSI-H high grade Mucoepidermoid carcinoma of the parotid gland with multiple metastases in the abdominal cavity.

Oral Oncol

The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing 210002, China. Electronic address:

Published: January 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2022.106190DOI Listing

Publication Analysis

Top Keywords

remarkable clinical
4
clinical response
4
response immune
4
immune checkpoint
4
checkpoint inhibitors
4
inhibitors msi-h
4
msi-h high
4
high grade
4
grade mucoepidermoid
4
mucoepidermoid carcinoma
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!